Gnak (Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Glucose, Sodium Acetate Trihydr)

Gnak is indicated for clinical situations where rapid restoration of intravascular volume and electrolyte balance is needed.

• Replacement of magnesium, potassium, sodium, and acetate in patients with documented deficiencies.
• Fluid resuscitation in hypovolemic shock, severe dehydration, or blood loss.
• Support during major surgery or trauma when electrolyte losses are anticipated.
• Management of metabolic acidosis when acetate can serve as a buffer.
• Adjunct therapy for patients receiving parenteral nutrition requiring additional electrolytes.

The safety profile of Gnak reflects the components of the solution; adverse events are generally related to the infusion itself or electrolyte shifts.

Common

• Mild infusion site irritation or erythema.
• Transient nausea or vomiting.
• Temporary increase in serum magnesium or potassium levels that resolve without intervention.
• Mild headache or dizziness during rapid infusion.

Serious

• Hypermagnesemia leading to muscle weakness, respiratory depression, or cardiac arrhythmia.
• Hyperkalemia causing cardiac conduction abnormalities.
• Fluid overload resulting in pulmonary edema or congestive heart failure.

When using Gnak, clinicians should evaluate patient-specific factors and monitor relevant parameters to minimize risk.

• Assess baseline electrolyte concentrations and renal function before initiation.
• Adjust infusion rate in patients with cardiac or renal impairment to avoid fluid overload.
• Avoid rapid administration in patients at risk for hypermagnesemia or hyperkalemia.
• Monitor serum magnesium, potassium, and sodium levels during and after infusion.
• Use caution in pregnant or breastfeeding individuals; safety data are limited.
• Discontinue if signs of allergic reaction, such as rash, itching, or respiratory distress, occur.

Gnak may interact with other medications that affect electrolyte balance or fluid status.

Avoid

• Concurrent use of other magnesium- or potassium-containing IV solutions without adjusting total dose.
• High-dose loop diuretics that can exacerbate electrolyte shifts when combined with Gnak.

Use with caution

• Calcium channel blockers, which may potentiate hypermagnesemia effects.
• ACE inhibitors or ARBs, as they can influence potassium handling.
• Blood products administered simultaneously, requiring careful monitoring of serum electrolytes.